Farallon Capital Management »

Vaxcyte shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $26M 377k 68.31

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Pioneer Natural Resources (PXD)
UnitedHealth (UNH)
Iqvia Holdings (IQV)
Exelixis (EXEL)
salesforce (CRM)
Aramark Hldgs (ARMK)
Nasdaq Omx (NDAQ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Transunion (TRU)
New York Times Cl A (NYT)
Ishares Tr Ishares Biotech Put Option (IBB)
Thermo Fisher Scientific (TMO)
Wabtec Corporation (WAB)

View all positions for Farallon Capital Management

Top funds holding Vaxcyte

FMR
Vanguard Group
BlackRock
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Investment Management
T. Rowe Price Associates
Darwin Global Management
Geode Capital Management
Franklin Resources
Perceptive Advisors
Alliancebernstein
Westfield Capital Management Company
Fred Alger Management

View all funds holding Vaxcyte